# ZEVALIN
> **BLA125019** · Biologics License Application · Sponsor: SPECTRUM PHARMS · Approved 2002-02-19
## Drug
- **FDA Application Number:** BLA125019
- **Application type:** Biologics License Application
- **Brand name:** ZEVALIN
- **Generic name:** IBRITUMOMAB TIUXETAN
- **Active ingredients:** IBRITUMOMAB TIUXETAN
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** SPECTRUM PHARMS
- **Manufacturer:** Acrotech Biopharma Inc
- **First approval:** 2002-02-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125019)
---
*AI Analytics · CC0 1.0*